Ignite Creation Date:
2025-12-24 @ 5:50 PM
Ignite Modification Date:
2026-02-22 @ 9:38 AM
Study NCT ID:
NCT01891968
Status:
COMPLETED
Last Update Posted:
2018-04-23
First Post:
2013-06-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-08-07
Start Date Type:
ACTUAL
Primary Completion Date:
2017-01-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-01-18
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-28
First Submit QC Date:
None
Study First Post Date:
2013-07-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-02-12
Results First Submit QC Date:
None
Results First Post Date:
2018-04-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-23
Last Update Post Date:
2018-04-23
Last Update Post Date Type:
ACTUAL